ホーム
マーケット
チャート&アイデア
Algo
ニュース
Store
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
VSTM
#2683
Verastem, Inc.
5.7
2
+1.42%
セクター:
ベース:
利益通貨:
日中レンジ
1年のレンジ
1日の変化
+1.42%
月次変化
-11.86%
6か月変化
-38.49%
1年の変化
+6.32%
以前の終値
5.6
4
Open
5.7
2
Bid
Ask
Low
5.7
2
High
5.7
2
ボリューム
58
マーケット
株
ヘルスケア
VSTM
Open full chart
Financials
Overview
明細書
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
14.31 M
15.53 M
16.72 M
25.3 M
51.49 M
—
Valuation ratios
Enterprise value
—
—
—
132.04 M
177.37 M
934.16 M
Price to earnings ratio
—
—
—
-2.11
-1.41
-6.34
Price to sales ratio
—
—
—
70.51
18.46
134.03
Price to cash flow ratio
—
—
—
2.12
1.76
8.8
Price to book ratio
—
—
—
3.19
-6.39
-39.24
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.44
0.66
0.78
0.58
1.29
1.72
Return on equity %
0.59
0.81
1.56
1.52
4.52
10.91
Return on invested capital %
555.17
3 623.48
7 730.47
7 773.12
6 173.32
4 621.49
Gross margin %
99.1
100
100
0
100
—
Operating margin %
55.76
2 991.18
2 809.59
-3 547.15
1 149.56
—
EBITDA margin %
-10.82
—
—
—
—
—
Net margin %
76.51
3 468.1
2 843.3
-3 365.45
1 306.37
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.48
5.69
4.29
5.45
3.07
12.61
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.59
0.02
0.03
0
0.08
0.09
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.12
0
0.26
0.27
0.4
1.76
Long term debt to total equity ratio
0.17
0
0.52
0.7
1.41
10.71
Per share metrics
Operating cash flow per share
2.62
3.68
3 945.57
3.92
2.93
2.35
EBIT per share
-1.72
—
—
—
—
—
EBITDA per share
-0.75
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
11.54
6.9
5 446.83
6.22
2.49
8.76
Net current asset value per share
11.34
7.28
5 754.8
6.52
2.66
9.42
Tangible book value per share
9.02
6.02
2 936.64
2.6
0.81
1.67
Working capital per share
10.01
6
4 412.43
5.32
1.79
6.4
Book value per share
9.02
6.02
2 936.64
2.6
0.81
2.11
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
ニュース
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
B.Rileyがベラステム株に対する「買い」評価を維持、目標価格16ドルを据え置き
B.Riley reiterates Buy rating on Verastem stock, maintains $16 target
ベラステム、がん治療薬の第4四半期収益17.5百万ドルを報告
Verastem reports $17.5 million in Q4 revenue for cancer treatment
Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
Revolution Medicines stock surges over 20% on potential AbbVie acquisition
アッヴィによる買収の可能性でレボリューション・メディシンズ株が20%超上昇
What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)
ベラステム株、みずほ証券が「アウトパフォーム」評価を維持